Squarepoint Ops LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$3,364,000
+28.5%
105,305
+39.3%
0.02%
+72.7%
Q1 2022$2,618,000
+106.0%
75,578
+74.0%
0.01%
+266.7%
Q4 2021$1,271,000
-3.7%
43,430
-16.2%
0.00%
-25.0%
Q3 2021$1,320,000
+182.7%
51,804
+288.6%
0.00%
+100.0%
Q2 2021$467,000
-6.2%
13,332
+9.0%
0.00%
-33.3%
Q1 2021$498,000
-32.4%
12,230
-28.1%
0.00%
-40.0%
Q4 2020$737,000
+114.2%
17,019
+172.4%
0.01%0.0%
Q3 2020$344,000
-88.3%
6,247
-86.6%
0.01%
-89.6%
Q2 2020$2,941,000
+492.9%
46,591
+379.7%
0.05%
+269.2%
Q1 2020$496,000
-66.6%
9,713
-48.0%
0.01%
+44.4%
Q4 2019$1,486,000
-50.4%
18,695
-69.7%
0.01%
-66.7%
Q3 2019$2,996,000
-12.9%
61,746
-5.6%
0.03%
-20.6%
Q2 2019$3,439,000
+210.9%
65,383
+212.8%
0.03%
+183.3%
Q1 2019$1,106,000
+78.1%
20,900
+38.0%
0.01%
+71.4%
Q4 2018$621,000
-39.5%
15,140
-43.9%
0.01%
-41.7%
Q3 2018$1,026,000
-23.8%
27,000
-9.4%
0.01%
-33.3%
Q2 2018$1,347,000
+51.5%
29,800
+62.0%
0.02%
+28.6%
Q1 2018$889,000
-46.1%
18,400
-56.1%
0.01%
-51.7%
Q4 2017$1,649,000
+19.0%
41,894
+11.4%
0.03%
-23.7%
Q1 2017$1,386,000
+216.4%
37,606
+24.0%
0.04%
+111.1%
Q4 2016$438,00030,3300.02%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2019
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders